Correction: Wu et al. Synthesis of Novel Lipophilic -Substituted Norcantharimide Derivatives and Evaluation of Their Anticancer Activities. 2014, , 6911-6928.
作者信息
Wu Jin-Yi, Kuo Cheng-Deng, Chu Chien-Yu, Chen Min-Shin, Lin Jia-Hua, Chen Yu-Jen, Liao Hui-Fen
机构信息
Department of Microbiology, Immunology and Biopharmaceutics, College of Life Sciences, National Chiayi University, Chiayi 60004, Taiwan.
Laboratory of Biophysics, Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
出版信息
Molecules. 2025 May 22;30(11):2256. doi: 10.3390/molecules30112256.
Abstract
In the original publication [...].
摘要
相似文献
1
Correction: Wu et al. Synthesis of Novel Lipophilic -Substituted Norcantharimide Derivatives and Evaluation of Their Anticancer Activities. 2014, , 6911-6928.
Molecules. 2025 May 22;30(11):2256. doi: 10.3390/molecules30112256.
2
Synthesis of novel lipophilic N-substituted norcantharimide derivatives and evaluation of their anticancer activities.
Molecules. 2014 May 26;19(6):6911-28. doi: 10.3390/molecules19066911.
3
Correction: Wu et al. Synthesis of Spirooxindole--Naphthoquinone-Tetrazolo[1,5-]Pyrimidine Hybrids as Potential Anticancer Agents. 2018, , 2330.
Molecules. 2024 Nov 7;29(22):5257. doi: 10.3390/molecules29225257.
4
Synthesis and biological evaluation of camptothecin substituted norcantharimide derivatives.
Nat Prod Res. 2021 Dec;35(24):5752-5756. doi: 10.1080/14786419.2020.1834546. Epub 2020 Oct 20.
5
Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.
Medicine (Baltimore). 2016 Aug;95(31):e4467. doi: 10.1097/MD.0000000000004467.
6
Correction: Shehabeldine et al. Antimicrobial, Antibiofilm, and Anticancer Activities of Essential Oil Nanoemulsion. 2023, , 5812.
Molecules. 2024 Nov 26;29(23):5574. doi: 10.3390/molecules29235574.
7
Correction: Gobinath, P., et al. Grindstone Chemistry: Design, One-Pot Synthesis, and Promising Anticancer Activity of Spiro[acridine-9,2'-indoline]-1,3,8-trione Derivatives against the MCF-7 Cancer Cell Line. 2020, , 5862.
Molecules. 2021 Feb 20;26(4):1131. doi: 10.3390/molecules26041131.
8
Synthesis, Spectroscopic Characterizations of Novel Norcantharimides, Their ADME Properties and Docking Studies Against COVID-19 M°.
ChemistrySelect. 2020 May 14;5(18):5422-5428. doi: 10.1002/slct.202001123. Epub 2020 May 12.
9
N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
Anticancer Drugs. 2015 Jun;26(5):508-17. doi: 10.1097/CAD.0000000000000210.
10
Correction: Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
Org Biomol Chem. 2017 Mar 1;15(9):2120-2121. doi: 10.1039/c7ob90028g.
本文引用的文献
1
Synthesis of novel lipophilic N-substituted norcantharimide derivatives and evaluation of their anticancer activities.
Molecules. 2014 May 26;19(6):6911-28. doi: 10.3390/molecules19066911.
Zotero 插件